Valo Therapeutics Ltd

📢 Valo Therapeutics Ltd has secured €19M in investment funding to advance the clinical development of its innovative immunotherapy for cancer. This funding will allow us to expand and complete the Phase 1B clinical study of our lead tumour antigen-coated oncolytic virus candidate. Clinical trials will be expanded to include Italy and Australia. The investment includes: 🔹 €13M financing co-led by Indaco Venture Partners and CDP Venture Capital SGR, with the support of Fondazione ENEA Tech e Biomedical. 🔹 €6M financing from Australian investors, supported by Freeman Road.   The financing will also support the creation of a subsidiary, Valo Therapeutics Italy Srl, based in Naples, with a focus on: ✅ Enrolling and treating patients in Southern Italy ✅ Initiating the large-scale manufacturing of viral vectors to support product development up to the commercial phase. ✅ Supporting research activities with institutions based in Naples and Southern Italy 🔗 Read the full press release here: https://lnkd.in/e2MzgZ5h #CancerResearch #Immunotherapy #Biotech #Investment #OncolyticVirus #LifeSciences David Hinton Giovanni Rizzo Francesca Ottier  Paul Porter

We’re proud to announce our partnership with Lisata Therapeutics, Inc. in a preclinical research collaboration that combines our PeptiCRAd platform with Lisata’s innovative certepetide. This collaboration aims to advance potential breakthroughs in cancer immunotherapy, focusing on combating melanoma using PeptiCRAd and certepetide alongside a checkpoint inhibitor. Our shared goal is to develop therapies that address the challenges of resistance, recurrence, and metastasis in melanoma treatment, aiming to improve patient outcomes by enhancing immune response within the tumour microenvironment. Stay tuned as we continue working to bring transformative solutions to cancer care! 🔗Read our press release: https://lnkd.in/exBE5nE2 #CancerResearch #Immunotherapy #Biotech #Pharma #Innovation 

What does the Finland biotech ecosystem look like? ❄️ While the land of a thousand lakes’s biotech effort is strongly directed toward sustainability, health is also a strong concern with innovative companies working on various solutions from immunotherapy to precision medicine. 💊 Here are seven biotech companies to know about in Finland! ⬇️ https://lnkd.in/d-Q4BGvQ #Finlandbiotech #biotechecosystem #sustainability #healthinnovation #immunotherapy #precisionmedicine #biotechcompanies #finnishbiotech #medicalresearch DelSiTech Ltd | Desentum Oy | Faron | Herantis Pharma Plc. | Nanoform | TILT Biotherapeutics Ltd | Valo Therapeutics Ltd | Terveysteknologia ry - Healthtech Finland | Health Incubator Helsinki | Finnish Bioindustries FIB - Suomen Bioteollisuus ry | Turku Bioscience | OuluHealth ecosystem